麥克奧迪(300341.SZ):非公開發行股票核准批覆到期
格隆匯12月3日丨麥克奧迪(300341.SZ)公佈,公司於2020年12月4日收到中國證監會《關於同意麥克奧迪(廈門)電氣股份有限公司向特定對象發行股票註冊的批覆》(證監許可〔2020〕3349號),同意公司向特定對象發行股票的註冊申請,該批覆自核準發行之日(2020年12月04日)起12個月內有效。
在取得上述批覆後,公司積極推進相關工作,因公司實際控制人變更,公司發展戰略優化,公司未能在批覆文件規定的有效期內完成該次非公開發行股票事宜,中國證監會關於公司該次非公開發行股票的批覆到期自動失效,保薦機構國金證券股份有限公司對公司的持續督導同時到期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.